COVID-19 is one of the biggest challenges facing medics and scientists around the world in the modern era. Despite the fact that considerable efforts have been made to treat COVID-19, the interaction of the virus with various organs and systems of the human body is still insufficiently studied. According to a number of authors, the clinical manifestations of COVID-19 can be represented not only by symptoms of damage to the respiratory system, but also by urogenital complications, in particular from the prostate gland. This article discusses the mechanisms of action of the SARS-CoV-2 virus on age-related patients with chronic prostatitis and/or benign prostatic hyperplasia, as well as ways to prevent the progression of prostate diseases caused by this virus.

Keywords: postcovid complications, bioregulatory peptides, COVID-19, vitaprost, benign prostatic hyperplasia, chronic prostatitis